JP2009533344A - 口腔ケア計画及びキット - Google Patents
口腔ケア計画及びキット Download PDFInfo
- Publication number
- JP2009533344A JP2009533344A JP2009504275A JP2009504275A JP2009533344A JP 2009533344 A JP2009533344 A JP 2009533344A JP 2009504275 A JP2009504275 A JP 2009504275A JP 2009504275 A JP2009504275 A JP 2009504275A JP 2009533344 A JP2009533344 A JP 2009533344A
- Authority
- JP
- Japan
- Prior art keywords
- oral
- plaque
- dentifrice
- antibacterial
- plan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000551 dentifrice Substances 0.000 claims abstract description 90
- 239000002324 mouth wash Substances 0.000 claims abstract description 54
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract description 40
- 210000000214 mouth Anatomy 0.000 claims abstract description 37
- 241000628997 Flos Species 0.000 claims abstract description 21
- 230000036541 health Effects 0.000 claims abstract description 14
- 239000000203 mixture Substances 0.000 claims description 51
- 230000001680 brushing effect Effects 0.000 claims description 48
- 229960001927 cetylpyridinium chloride Drugs 0.000 claims description 29
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 claims description 29
- 229940051866 mouthwash Drugs 0.000 claims description 28
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 claims description 18
- 239000003242 anti bacterial agent Substances 0.000 claims description 17
- 229960003500 triclosan Drugs 0.000 claims description 16
- 230000000694 effects Effects 0.000 claims description 15
- 239000004599 antimicrobial Substances 0.000 claims description 12
- 230000008929 regeneration Effects 0.000 claims description 11
- 238000011069 regeneration method Methods 0.000 claims description 11
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 claims description 10
- 208000007565 gingivitis Diseases 0.000 claims description 9
- 230000001225 therapeutic effect Effects 0.000 claims description 8
- 239000000341 volatile oil Substances 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 206010006326 Breath odour Diseases 0.000 claims description 7
- -1 triclosan monophosphate Chemical class 0.000 claims description 7
- 150000002978 peroxides Chemical class 0.000 claims description 6
- 229920000388 Polyphosphate Polymers 0.000 claims description 5
- 239000001205 polyphosphate Substances 0.000 claims description 5
- 235000011176 polyphosphates Nutrition 0.000 claims description 5
- 125000001453 quaternary ammonium group Chemical group 0.000 claims description 5
- IUTCEZPPWBHGIX-UHFFFAOYSA-N tin(2+) Chemical compound [Sn+2] IUTCEZPPWBHGIX-UHFFFAOYSA-N 0.000 claims description 5
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 claims description 4
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 claims description 4
- 229960003260 chlorhexidine Drugs 0.000 claims description 4
- 208000002925 dental caries Diseases 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 claims description 3
- 235000012054 meals Nutrition 0.000 claims description 3
- YFVBASFBIJFBAI-UHFFFAOYSA-M 1-tetradecylpyridin-1-ium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCC[N+]1=CC=CC=C1 YFVBASFBIJFBAI-UHFFFAOYSA-M 0.000 claims description 2
- ANAAMBRRWOGKGU-UHFFFAOYSA-M 4-ethyl-1-tetradecylpyridin-1-ium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCC[N+]1=CC=C(CC)C=C1 ANAAMBRRWOGKGU-UHFFFAOYSA-M 0.000 claims description 2
- 239000003906 humectant Substances 0.000 claims description 2
- 150000005846 sugar alcohols Polymers 0.000 claims description 2
- 239000000606 toothpaste Substances 0.000 claims description 2
- 229940034610 toothpaste Drugs 0.000 claims 1
- 238000011282 treatment Methods 0.000 abstract description 27
- 230000008901 benefit Effects 0.000 abstract description 15
- 230000002087 whitening effect Effects 0.000 abstract description 9
- 239000013543 active substance Substances 0.000 abstract description 8
- 230000002882 anti-plaque Effects 0.000 abstract description 6
- 230000002272 anti-calculus Effects 0.000 abstract description 4
- 230000003750 conditioning effect Effects 0.000 abstract description 2
- 238000000586 desensitisation Methods 0.000 abstract description 2
- 238000005498 polishing Methods 0.000 abstract description 2
- 239000000047 product Substances 0.000 description 40
- 239000003795 chemical substances by application Substances 0.000 description 20
- 238000000034 method Methods 0.000 description 17
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 description 15
- 229960002799 stannous fluoride Drugs 0.000 description 15
- 239000001301 oxygen Substances 0.000 description 14
- 229910052760 oxygen Inorganic materials 0.000 description 14
- 238000005259 measurement Methods 0.000 description 13
- 241000894006 Bacteria Species 0.000 description 12
- 239000012459 cleaning agent Substances 0.000 description 12
- 239000000499 gel Substances 0.000 description 10
- 210000001519 tissue Anatomy 0.000 description 10
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 9
- 238000003384 imaging method Methods 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- 239000003086 colorant Substances 0.000 description 8
- 239000002537 cosmetic Substances 0.000 description 8
- 239000003599 detergent Substances 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 244000005700 microbiome Species 0.000 description 8
- 208000028169 periodontal disease Diseases 0.000 description 8
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 7
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 6
- 230000000845 anti-microbial effect Effects 0.000 description 6
- 238000010186 staining Methods 0.000 description 6
- 238000011161 development Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 239000008363 phosphate buffer Substances 0.000 description 5
- 230000002265 prevention Effects 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 208000002064 Dental Plaque Diseases 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 235000021156 lunch Nutrition 0.000 description 4
- 230000007505 plaque formation Effects 0.000 description 4
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 230000001629 suppression Effects 0.000 description 4
- 230000009885 systemic effect Effects 0.000 description 4
- 206010048685 Oral infection Diseases 0.000 description 3
- 208000008312 Tooth Loss Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 230000035622 drinking Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 238000010191 image analysis Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 229940076522 listerine Drugs 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 3
- 208000031729 Bacteremia Diseases 0.000 description 2
- 231100000699 Bacterial toxin Toxicity 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- 208000005189 Embolism Diseases 0.000 description 2
- 229920001503 Glucan Polymers 0.000 description 2
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 2
- 208000025157 Oral disease Diseases 0.000 description 2
- 241000605862 Porphyromonas gingivalis Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000000688 bacterial toxin Substances 0.000 description 2
- 230000003542 behavioural effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- CEZCCHQBSQPRMU-UHFFFAOYSA-L chembl174821 Chemical compound [Na+].[Na+].COC1=CC(S([O-])(=O)=O)=C(C)C=C1N=NC1=C(O)C=CC2=CC(S([O-])(=O)=O)=CC=C12 CEZCCHQBSQPRMU-UHFFFAOYSA-L 0.000 description 2
- 239000013043 chemical agent Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000002301 combined effect Effects 0.000 description 2
- NJDNXYGOVLYJHP-UHFFFAOYSA-L disodium;2-(3-oxido-6-oxoxanthen-9-yl)benzoate Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=CC(=O)C=C2OC2=CC([O-])=CC=C21 NJDNXYGOVLYJHP-UHFFFAOYSA-L 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 235000012732 erythrosine Nutrition 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 208000030194 mouth disease Diseases 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 201000001245 periodontitis Diseases 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 235000013024 sodium fluoride Nutrition 0.000 description 2
- 239000011775 sodium fluoride Substances 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical group OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
- UBVSIAHUTXHQTD-UHFFFAOYSA-N 2-n-(4-bromophenyl)-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC=NC(NC=2C=CC(Br)=CC=2)=N1 UBVSIAHUTXHQTD-UHFFFAOYSA-N 0.000 description 1
- VDBJCDWTNCKRTF-UHFFFAOYSA-N 6'-hydroxyspiro[2-benzofuran-3,9'-9ah-xanthene]-1,3'-dione Chemical compound O1C(=O)C2=CC=CC=C2C21C1C=CC(=O)C=C1OC1=CC(O)=CC=C21 VDBJCDWTNCKRTF-UHFFFAOYSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- 239000004343 Calcium peroxide Substances 0.000 description 1
- 240000007154 Coffea arabica Species 0.000 description 1
- 241001634499 Cola Species 0.000 description 1
- 208000006558 Dental Calculus Diseases 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 208000012868 Overgrowth Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- INVGWHRKADIJHF-UHFFFAOYSA-N Sanguinarin Chemical class C1=C2OCOC2=CC2=C3[N+](C)=CC4=C(OCO5)C5=CC=C4C3=CC=C21 INVGWHRKADIJHF-UHFFFAOYSA-N 0.000 description 1
- 241000194023 Streptococcus sanguinis Species 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- FMRLDPWIRHBCCC-UHFFFAOYSA-L Zinc carbonate Chemical compound [Zn+2].[O-]C([O-])=O FMRLDPWIRHBCCC-UHFFFAOYSA-L 0.000 description 1
- 238000002679 ablation Methods 0.000 description 1
- 239000003082 abrasive agent Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 206010000891 acute myocardial infarction Diseases 0.000 description 1
- 230000002730 additional effect Effects 0.000 description 1
- 241001148470 aerobic bacillus Species 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 239000004191 allura red AC Substances 0.000 description 1
- 235000012741 allura red AC Nutrition 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000003610 anti-gingivitis Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- LHJQIRIGXXHNLA-UHFFFAOYSA-N calcium peroxide Chemical compound [Ca+2].[O-][O-] LHJQIRIGXXHNLA-UHFFFAOYSA-N 0.000 description 1
- 235000019402 calcium peroxide Nutrition 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 229940078916 carbamide peroxide Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000019884 chronic gingivitis Diseases 0.000 description 1
- 150000001867 cobalamins Chemical class 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 210000004268 dentin Anatomy 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- IINNWAYUJNWZRM-UHFFFAOYSA-L erythrosin B Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 IINNWAYUJNWZRM-UHFFFAOYSA-L 0.000 description 1
- 239000004174 erythrosine Substances 0.000 description 1
- 229940011411 erythrosine Drugs 0.000 description 1
- 229920000295 expanded polytetrafluoroethylene Polymers 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 150000004673 fluoride salts Chemical class 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 210000004195 gingiva Anatomy 0.000 description 1
- 229940005740 hexametaphosphate Drugs 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229910052751 metal Chemical class 0.000 description 1
- 239000002184 metal Chemical class 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- 229940095518 mouthwash product Drugs 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000010585 negative regulation of hypersensitivity Effects 0.000 description 1
- 239000013588 oral product Substances 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 230000003239 periodontal effect Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- GVKCHTBDSMQENH-UHFFFAOYSA-L phloxine B Chemical compound [Na+].[Na+].[O-]C(=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C([O-])=C(Br)C=C21 GVKCHTBDSMQENH-UHFFFAOYSA-L 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000001044 red dye Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229940085605 saccharin sodium Drugs 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 210000001581 salivary duct Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229910001631 strontium chloride Inorganic materials 0.000 description 1
- AHBGXTDRMVNFER-UHFFFAOYSA-L strontium dichloride Chemical compound [Cl-].[Cl-].[Sr+2] AHBGXTDRMVNFER-UHFFFAOYSA-L 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 150000003464 sulfur compounds Chemical class 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000007910 systemic administration Methods 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 235000019505 tobacco product Nutrition 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 206010048828 underweight Diseases 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 235000004416 zinc carbonate Nutrition 0.000 description 1
- 239000011667 zinc carbonate Substances 0.000 description 1
- 229910000010 zinc carbonate Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
- A61K8/21—Fluorides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/22—Peroxides; Oxygen; Ozone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/24—Phosphorous; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
- A61K8/416—Quaternary ammonium compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/43—Guanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/88—Two- or multipart kits
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Cosmetics (AREA)
Abstract
(a)抗菌性歯磨剤を口腔表面に適用する工程と、
(b)前記口腔を抗菌性口内洗浄剤ですすぐ工程と、
をそれぞれ少なくとも1日1回含み、この際、工程(a)及び(b)の少なくとも一方は、夜就寝する前に行われる。好ましくは前記計画は、工程(c)として、口腔の歯間、歯肉、及び歯肉縁下の領域を、デンタルフロス、フロスピック、デンタルテープ、及びプロキシブラシから選択される歯間用具を用いて処置する工程を含み、この際工程(c)は工程(a)及び(b)の一方又は両方の直前又は直後に行われる。
Description
(a)抗菌性歯磨剤を口腔表面に適用する工程と、
(b)前記口腔を抗菌性口内洗浄剤ですすぐ工程と、
をそれぞれ少なくとも1日1回含み、好ましくは、工程(a)及び(b)の少なくとも一方は、夜就寝する前に行われる。
(i)有効抗菌量の第一スズイオン源と、
(ii)有効抗虫歯量のフッ化物イオン源と、
(iii)約4以上の平均鎖長を有する1以上の線状(linear)ポリホスフェート類と、
を含む歯磨剤で、歯及び口腔表面を歯ブラシを用いてブラッシングすることを含む。
(i)塩化セチルピリジニウム(CPC)、塩化テトラデシルピリジニウム、塩化N−テトラデシル−4−エチルピリジニウム、臭化ドミフェン、及びこれらの混合物からなる群から選択される生物学的に利用可能な四級アンモニウム抗菌剤を少なくとも約300ppm送達するための量の四級アンモニウム抗菌剤の1つ又は混合物と、
(ii)大部分の水、及び組成物の約5重量%〜約30重量%の多価アルコール保湿剤を含む、薬学上許容される液体キャリアと、
を含む、口内洗浄剤で歯及び口腔表面をすすぐことを包含する工程(b)が続く。
この調査においては、系統的口腔ケア衛生計画中に抗菌剤を含有する製品形態(歯磨剤及び口内洗浄剤)を組み合わせることの効果を、1つの形態のみ(抗菌性歯磨剤又は口内洗浄剤)の使用と比較して評価した。以下の計画(A〜F)を評価するために所望の口腔の結果として息の状態の改善を使用した。
B.フッ化第一スズ歯磨剤[クレスト(登録商標)プロヘルス(PRO-HEALTH)(商標)歯磨剤(CPHD)]
C.トリクロサン歯磨剤+精油口内洗浄剤[コルゲートトータル(Colgate Total)(登録商標)歯磨剤+リステリン(Listerine)(登録商標)口内洗浄剤(それぞれコルゲート・パルムオリーブ(Colgate-Palmolive)及びファイザー(Pfizer, Inc.)により製造)]
D.フッ化ナトリウム歯磨剤+塩化セチルピリジニウム(CPC)口内洗浄剤[クレスト(Crest)(登録商標)キャビティープロテクション(Cavity Protection)(CCP)歯磨剤+クレスト(Crest)(登録商標)プロヘルス(PRO-HEALTH)(商標)口内洗浄剤(CPHR)(プロクター・アンド・ギャンブル(The Procter & Gamble Co.)により製造)]
E.フッ化第一スズ歯磨剤+塩化セチルピリジニウム(CPC)口内洗浄剤[クレスト(Crest)(登録商標)プロヘルス(PRO-HEALTH)(商標)歯磨剤(CPHD)+クレスト(Crest)(登録商標)プロヘルス(PRO-HEALTH)(商標)口内洗浄剤(CPHR)(プロクター・アンド・ギャンブル(The Procter & Gamble Co.)により製造)、朝晩の使用]
F.フッ化第一スズ歯磨剤+塩化セチルピリジニウム(CPC)口内洗浄剤[クレスト(Crest)(登録商標)プロヘルス(PRO-HEALTH)(商標)歯磨剤(CPHD)+クレスト(Crest)(登録商標)プロヘルス(PRO-HEALTH)(商標)口内洗浄剤(CPHR)、朝晩の歯磨剤の使用、昼食後及び夕食後の口内洗浄剤の使用]
臨床試験は単一施設、試験者目隠し、6処置、6期間、オープンラベル、交差研究であった。このプロトコルとは別に行われたスクリーニングの実行に基づいて再現可能な悪臭の徴候を示した30人の被験者がこの調査に登録された。息の測定は各処置期間のベースラインにおいて及びベースライン後およそ24時間及び48時間に行われた。各調査訪問時にハリメーター(Halimeter)測定が行われた。測定は、朝、あらゆる口腔衛生が行われる前に行われた。被験者は、ハリメーター(Halimeter)(インタースキャン・コーポレーション(Interscan Corporation)、カリフォルニア)と呼ばれる市販の携帯用計器を用いて、揮発性イオウ化合物(VSC)の放出について評価された。この計器は、不快な口臭の主要構成成分のうちの2つである、硫化水素及びメチルメルカプタンに感応性である。熟練した技術者が全てのハリメーター(Halimeter)測定を実行した。製造メーカーによって記載された手順にしたがってハリメーター(Halimeter)の較正を行った。
この調査により、本計画からの歯垢再生抑制効果が実証された。口中の細菌性歯垢の抑制は、虫歯、歯肉炎、歯周病、及び歯の欠損を包含する口腔状態を防止するために必須である。歯垢を抑制するために、機械的な歯の洗浄行動(歯のブラッシング、フロシング、すすぎ)が、化学剤(抗菌剤又は表面への細菌の付着を防止し又は歯垢を分離する剤)と組み合わせて使用される。歯垢の再生及び生命力と歯肉炎への感染しやすさとの一般的相関により、治療活性の効果と持続性とを組み合わせた潜在能力を定量化するためには、計画の抗歯垢特性を、特に一日を通して評価するのが理想的であり得るということが示唆される。歯垢の洗浄又は除去及び歯垢形成又は再生の抑制の評価のために使用される方法は、ホワイト(White)ら、ジャーナル・オブ・クリニカル・デンティストリー(J Clin Dent)17:22〜26、2006年に記載されているDPIARM技術(デジタル歯垢画像分析の反復測定(Repeated Measures Digital Plaque Image Analysis))である。
□25mlのホスフェート緩衝剤で10秒間すすぐ;
□ホスフェート緩衝剤中1240ppmフルオレセイン5.0mlで1分間すすぐ;
□25mlのホスフェート緩衝剤で10秒間×3回すすぐ。
本調査では、抗菌性歯磨剤(フッ化第一スズ+ヘキサメタホスフェート、クレスト(Crest)(登録商標)プロヘルス(PRO-HEALTH)(商標)、CPHD)及び電動歯ブラシ(オーラルB(Oral-B)(登録商標)トリンプ(Triumph)(商標)、OBT)の付加的有効性を、介入に基づくデジタル歯垢画像分析法(DPIA)において評価した。16人の被験者に、市販のクレスト(Crest)(登録商標)キャビティープロテクション(Cavity Protection)歯磨剤(CCP)のチューブ及びオーラルB(Oral-B)(登録商標)トリンプ(Triumph)(商標)プロフェッショナルケア(Professional Care)9000(商標)歯ブラシ(CCP−OBT)を朝晩のブラッシングの努力に関する指示と共に渡した。被験者はそのCCP−OBT計画を2週間続けた。2週間の間、日中の歯垢レベルに関して、午前中のブラッシング前;午前中のブラッシング後;及び午後(午後の真ん中)の各歯垢再生の評価をそれぞれ包含する3日間の別個の採点日に、前述したような規格化UV画像化技術(ホワイト(White)ら、ジャーナル・オブ・クリニカル・デンティストリー(J Clin Dent)17:22〜26、2006年)を用いて被験者を評価した。3週目に、被験者はCCP歯磨剤を抗菌性フッ化第一スズ歯磨剤(CPHD)と交換し、被験者は更に2週間ブラッシングを続け、4週間の間歯垢を再評価した。
部分的に更に組み合わせることができ、このような歯ブラシの例は、米国特許第5,998,431号、及び同第6,009,589号に開示されている。前述した製品のいずれも、組み合わせて及びキットとして包装し、口腔ケア構成要素類の単一のシステムとして分配することができる。
2 ICLパフォーマンス・プロダクツ(ICL Performance Products)により供給される平均鎖長18〜30のポリホスフェート
3 甘味剤はサッカリンナトリウム、スクラロース、又はこれらの混合物である。
4 着色剤は歯垢染色剤を包含してよい。
2 ICLパフォーマンス・プロダクツ(ICL Performance Products)により供給される平均鎖長18〜30のポリホスフェート
3 着色剤は歯垢染色剤を包含してよい。
Claims (10)
- 最適な口腔の健康及び衛生を達成するための口腔衛生計画であって、下記工程:
(a)抗菌性フッ化物歯磨剤で、好ましくは電動歯ブラシを用いて、歯及び口腔表面をブラッシングする工程と、
(b)前記口腔を抗菌性口内洗浄剤ですすぐ工程と、
をそれぞれ少なくとも1日1回含み、
工程a)及びb)の少なくとも一方は、夜就寝する前に行われ、前記計画は、口中での有効な抗菌活性、並びに歯垢、歯垢の再生、虫歯、結石、歯肉炎、及び口臭のうちの1つ以上を軽減又は抑制する効果を提供する、計画。 - 工程(c)として、歯間、歯肉、及び歯肉縁下の領域を、デンタルフロス、フロスピック、デンタルテープ、及びプロキシブラシから選択される歯間用具を用いて処置する工程を更に含み、この際工程(c)は工程(a)及び(b)の一方又は両方の直前又は直後に行われ、好ましくは工程(a)〜(c)はそれぞれ少なくとも1日2回行われ、及び好ましくは前記歯間用具は抗菌剤を組み込んでいる、請求項1に記載の計画。
- 前記工程(a)と(b)とは、少なくとも約30分間間隔をあける、請求項1に記載の計画。
- 工程(a)又は工程(b)のうちの少なくとも一方は食後に行われる、請求項1に記載の計画。
- 工程(a)が、
(i)有効抗菌量の第一スズイオン源と、
(ii)有効抗虫歯量のフッ化物イオン源と、
(iii)4以上の平均鎖長を有する1以上の線状ポリホスフェートと、
を含む歯磨剤で、歯及び口腔表面をブラッシングすることを含む、請求項1に記載の計画。 - 工程(b)が、
(i)塩化セチルピリジニウム、塩化テトラデシルピリジニウム、塩化N−テトラデシル−4−エチルピリジニウム、臭化ドミフェン、及びこれらの混合物からなる群から選択される生物学的に利用可能な四級アンモニウム抗菌剤を少なくとも300ppm送達するための量の四級アンモニウム抗菌剤の1つ又は混合物、好ましくは組成物の少なくとも0.035重量%の塩化セチルピリジニウムと、
(ii)大部分の水、及び組成物の5重量%〜30重量%の多価アルコール保湿剤を含む、薬学上許容される液体キャリアと、
を含む口内洗浄剤で、歯及び口腔表面をすすぐことを含む、請求項1に記載の計画。 - 歯磨剤又は口内洗浄剤のいずれかが、歯垢が蓄積された領域を確認するための歯垢染色剤を含む、請求項1に記載の計画。
- 抗菌性フッ化物歯磨剤;歯ブラシ;抗菌性口内洗浄剤;歯間用具;及び下記工程:
(a)歯及び口腔表面を前記歯磨剤でブラッシングする工程と、
(b)前記口腔を前記口内洗浄剤ですすぐ工程と、
をそれぞれ少なくとも1日1回含む毎日の計画のための指示書を含む、口腔衛生キットであって、
工程(a)及び(b)の少なくとも一方は夜就寝する前に行われ、
前記練り歯磨きが、
(i)第一スズイオン源、亜鉛イオン源、トリクロサン、過酸化物源、塩化セチルピリジニウム、クロルへキシジン、トリクロサン、トリクロサンモノホスフェート、精油類、及びこれらの混合物から選択される、安全且つ治療に有効な量の抗菌剤と、
(ii)安全且つ有効な量のフッ化物イオン源と、
(iii)研磨剤と、
を含み、
前記口内洗浄剤は、
(i)第一スズイオン源、亜鉛イオン源、トリクロサン、過酸化物源、塩化セチルピリジニウム、臭化ドミフェン、クロルヘキシジン、トリクロサン、トリクロサンモノホスフェート、精油類、及びこれらの混合物から選択される、安全且つ治療に有効な量の抗菌剤と、
(ii)水性液体キャリアと、
を含み、
好ましくは、前記歯ブラシは電動歯ブラシであり、好ましくは、歯垢が蓄積された領域を確認するための歯垢染色剤を更に含んでなるキット。 - 前記歯垢染色剤が、前記歯磨剤、口内洗浄剤、又は歯間用具のうちのいずれか1つの構成要素であるか、又は前記キットに包含される別個の口腔ケア製品の構成要素である、請求項8に記載の口腔衛生キット。
- 工程(a)又は工程(b)の少なくとも一方を食後に行うための指示書を包含する、請求項8に記載の口腔衛生キット。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US79050506P | 2006-04-07 | 2006-04-07 | |
PCT/US2007/008377 WO2007117498A2 (en) | 2006-04-07 | 2007-04-05 | Oral care regimens and kits |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2009533344A true JP2009533344A (ja) | 2009-09-17 |
Family
ID=38353819
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009504275A Pending JP2009533344A (ja) | 2006-04-07 | 2007-04-05 | 口腔ケア計画及びキット |
Country Status (11)
Country | Link |
---|---|
US (1) | US20070237726A1 (ja) |
EP (1) | EP2004134A2 (ja) |
JP (1) | JP2009533344A (ja) |
CN (1) | CN101495085A (ja) |
AU (1) | AU2007235491A1 (ja) |
BR (1) | BRPI0710643A2 (ja) |
CA (1) | CA2648679C (ja) |
MX (1) | MX2008012908A (ja) |
MY (1) | MY157987A (ja) |
RU (1) | RU2493816C2 (ja) |
WO (1) | WO2007117498A2 (ja) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009536663A (ja) * | 2006-05-09 | 2009-10-15 | コルゲート・パーモリブ・カンパニー | 口腔ケア措置 |
JP2017523218A (ja) * | 2014-08-15 | 2017-08-17 | ザ プロクター アンド ギャンブル カンパニー | 漸増式薬品を有する歯磨剤 |
JP2017523993A (ja) * | 2014-08-15 | 2017-08-24 | ザ プロクター アンド ギャンブル カンパニー | 強化された感覚的経験を有する口腔ケア組成物 |
JP2017524711A (ja) * | 2014-08-15 | 2017-08-31 | ザ プロクター アンド ギャンブル カンパニー | 口腔ケア組成物及びレジメン |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2009005033A (es) * | 2006-11-13 | 2009-06-26 | Procter & Gamble | Productos y metodos para determinar enfermedades en la cavidad bucal. |
CN101848694A (zh) * | 2007-11-09 | 2010-09-29 | 宝洁公司 | 亚锡口腔组合物 |
RU2505798C2 (ru) | 2008-04-04 | 2014-01-27 | Колгейт-Палмолив Компани | Анализ субстратов, на которые нанесены агенты |
EP2191788A1 (en) * | 2008-11-29 | 2010-06-02 | Braun Gmbh | Method and device for three-dimensional measurement of a dental model |
GB0822434D0 (en) * | 2008-12-09 | 2009-01-14 | Glaxo Group Ltd | Novel use |
MY159488A (en) | 2009-10-29 | 2017-01-13 | Colgate Palmolive Co | Dentifrice comprising stannous fluoride plus zinc citrate and low levels of water |
MX2012006170A (es) * | 2009-12-21 | 2012-06-19 | Colgate Palmolive Co | Kit que contiene colorantes de fotosensibilizacion. |
CN102958566A (zh) * | 2010-06-30 | 2013-03-06 | 高露洁-棕榄公司 | 口腔健康指数 |
WO2012103264A1 (en) * | 2011-01-25 | 2012-08-02 | Slh Optimal Health Llc | Dental cleaning composition comprising purple carrot extract |
JP6404216B2 (ja) | 2012-09-11 | 2018-10-10 | エスエルエイチ オプティマル ヘルス エルエルシーSlh Optimal Health Llc | 歯の清掃組成物 |
EP3897530A1 (en) | 2018-12-21 | 2021-10-27 | Unilever IP Holdings B.V. | Antimicrobial compositions comprising modified clay and nonionic triblock copolymers |
RU2739757C2 (ru) * | 2019-02-05 | 2020-12-28 | Сергей Анатольевич Холодов | Способ ухода за полостью рта |
JP7237207B2 (ja) * | 2019-06-14 | 2023-03-10 | ザ プロクター アンド ギャンブル カンパニー | 洗い流さない口腔ケア組成物 |
JP7288090B2 (ja) | 2019-06-14 | 2023-06-06 | ザ プロクター アンド ギャンブル カンパニー | 洗い流さない口腔ケア組成物 |
EP3982913A1 (en) | 2019-06-14 | 2022-04-20 | The Procter & Gamble Company | Leave-on oral care compositions |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10175835A (ja) * | 1996-12-18 | 1998-06-30 | Atsushi Takatori | 歯垢染色歯磨剤 |
JP2004083443A (ja) * | 2002-08-23 | 2004-03-18 | Hideji Watanabe | マスティックを用いた歯周病予防・治療用組成物及び歯周病予防・治療方法 |
WO2005030141A2 (en) * | 2003-09-26 | 2005-04-07 | Morinda, Inc. | Morinda citrifolia-based oral care compositions and methods |
WO2006020875A2 (en) * | 2004-08-12 | 2006-02-23 | The Procter & Gamble Company | Oral compositions and systems |
Family Cites Families (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3309274A (en) * | 1962-07-23 | 1967-03-14 | Brilliant Herbert | Use of fluorescent dyes in dental diagnostic methods |
US3624219A (en) * | 1970-07-06 | 1971-11-30 | Max J Perlitsh | Plaque-disclosing composition and package system |
US3758689A (en) * | 1971-03-24 | 1973-09-11 | I Rapfogel | Method of treating periodontal disease |
US3830246A (en) * | 1972-05-26 | 1974-08-20 | B Gillings | Fluoride impregnated dental floss |
US3997658A (en) * | 1973-03-22 | 1976-12-14 | Block Philip L | Dental plaque disclosing compositions |
GB1560757A (en) * | 1976-04-07 | 1980-02-06 | Selwyn S | Dental plaque disclosing agent |
US4138477A (en) * | 1976-05-28 | 1979-02-06 | Colgate Palmolive Company | Composition to control mouth odor |
US4459277A (en) * | 1980-10-07 | 1984-07-10 | Kosti Carl M | Plaque disclosing dentifrice compositions with solid microcapsules of dye |
US4666700A (en) * | 1982-01-22 | 1987-05-19 | Howard Frysh | Disclosing of plaque on teeth |
US4590061A (en) * | 1983-12-29 | 1986-05-20 | Vipont Laboratories, Inc. | Antimicrobial plaque disclosing agent |
US4517172A (en) * | 1983-12-29 | 1985-05-14 | Vipont Laboratories, Inc. | Plaque disclosing agent |
US5004597A (en) * | 1987-09-14 | 1991-04-02 | The Procter & Gamble Company | Oral compositions comprising stannous flouride and stannous gluconate |
US4992256A (en) * | 1989-09-27 | 1991-02-12 | Colgate-Palmolive Company | Plaque disclosing compositions |
US5009883A (en) * | 1989-11-15 | 1991-04-23 | Gillette Canada Inc. | Aqueous stannous fluoride non-abrasive home treatment gel compositions |
US5017363A (en) * | 1989-11-15 | 1991-05-21 | Gillette Canada, Inc. | Stabilized stannous fluoride toothpaste |
ES2114557T3 (es) * | 1990-12-13 | 1998-06-01 | Gemtech Inc | Cepillo de dientes para entregar dentifrico/medicacion. |
US5098691A (en) * | 1991-05-06 | 1992-03-24 | Colgate-Palmolive Company | Composition for disclosing dental plaque |
US5190743A (en) * | 1991-05-06 | 1993-03-02 | Colgate-Palmolive Company | Composition for disclosing dental plaque |
BR9206408A (pt) * | 1991-08-23 | 1994-11-22 | Gillette Canada | Escova oral, matriz de liberação prolongada, processo para liberar um agente antimicrobiano de uma escova oral e para liberação de um agente antimicrobiano na boca de um animal e escova oral indicadora de desgaste |
US5378153A (en) * | 1992-02-07 | 1995-01-03 | Gemtech, Inc. | High performance acoustical cleaning apparatus for teeth |
US5302375A (en) * | 1992-11-19 | 1994-04-12 | Colgate-Palmolive Company | Oral composition having improved tooth whitening effect |
DE4317407C1 (de) * | 1993-05-26 | 1994-08-18 | Braun Ag | Bürstenteil für eine Zahnbürste |
US20030206874A1 (en) * | 1996-11-21 | 2003-11-06 | The Proctor & Gamble Company | Promoting whole body health |
US6350436B1 (en) * | 1996-11-21 | 2002-02-26 | The Procter & Gamble Company | Method of reducing staining of stannous in dentifrice compositions |
US6187295B1 (en) * | 1996-11-21 | 2001-02-13 | The Procter & Gamble Company | Methods of reducing the astringency of stannous in dentifrice compositions |
US6713049B1 (en) * | 1999-11-12 | 2004-03-30 | The Procter & Gamble Company | Oral compositions providing optimal surface conditioning |
US5939052A (en) * | 1996-11-21 | 1999-08-17 | The Procter & Gamble Company | Dentifrice compositions containing polyphosphate and fluoride |
US5871715A (en) * | 1997-02-28 | 1999-02-16 | Gillette Canada Inc. | Stannous fluoride gel with improved stand-up |
US5879691A (en) * | 1997-06-06 | 1999-03-09 | The Procter & Gamble Company | Delivery system for a tooth whitener using a strip of material having low flexural stiffness |
US6096328A (en) * | 1997-06-06 | 2000-08-01 | The Procter & Gamble Company | Delivery system for an oral care substance using a strip of material having low flexural stiffness |
DE69839997D1 (de) * | 1997-06-20 | 2008-10-23 | Biolase Tech Inc | System mit elektromagnetische strahlung emittierender zahnbürste und zahnpasta |
AU2738000A (en) * | 1999-01-27 | 2000-08-18 | Bioglobe Tech, Inc. | Oral hygiene preparations; associated methods and kit |
RU2157180C1 (ru) * | 1999-03-30 | 2000-10-10 | КОЛЕСНИКОВА Валерия Георгиевна | Способ гигиенического ухода за состоянием ротовой полости и зубов |
US6649147B1 (en) * | 1999-07-02 | 2003-11-18 | The Procter & Gamble Company | Delivery system for oral care compositions comprising organosiloxane resins using a removable backing strip |
MXPA02004783A (es) * | 1999-11-12 | 2002-08-30 | Procter & Gamble | Composiciones orales estannosas en dos fases mejoradas. |
JP3860471B2 (ja) * | 1999-11-12 | 2006-12-20 | ザ プロクター アンド ギャンブル カンパニー | 改良された第1錫系口腔組成物 |
US6685920B2 (en) * | 1999-11-12 | 2004-02-03 | The Procter & Gamble Company | Method of protecting teeth against erosion |
JP2004517038A (ja) * | 2000-06-30 | 2004-06-10 | ザ、プロクター、エンド、ギャンブル、カンパニー | 全身の健康増進 |
US6648641B1 (en) * | 2000-11-22 | 2003-11-18 | The Procter & Gamble Company | Apparatus, method and product for treating teeth |
AU2002227247A1 (en) * | 2000-12-08 | 2002-06-18 | Brown, Dale G. | Biofilm therapy process and elements |
US20020088474A1 (en) * | 2000-12-26 | 2002-07-11 | Montalvo Michael D. | Coolbrush oral hygiene system |
US6526991B2 (en) * | 2000-12-28 | 2003-03-04 | Mark Anthony Bodwalk | Oral hygiene travel kit |
US6509007B2 (en) * | 2001-03-19 | 2003-01-21 | The Procter & Gamble Company | Oral care kits and compositions |
EP1448159B1 (en) * | 2001-11-28 | 2010-06-02 | The Procter & Gamble Company | Dentifrice compositions |
US20030098249A1 (en) * | 2001-11-28 | 2003-05-29 | Rollock Debra Anita | Brace case |
US7166235B2 (en) * | 2002-05-09 | 2007-01-23 | The Procter & Gamble Company | Compositions comprising anionic functionalized polyorganosiloxanes for hydrophobically modifying surfaces and enhancing delivery of active agents to surfaces treated therewith |
US7025950B2 (en) * | 2002-05-09 | 2006-04-11 | The Procter & Gamble Company | Oral care compositions comprising dicarboxy functionalized polyorganosiloxanes |
US7182935B2 (en) * | 2002-06-19 | 2007-02-27 | Empresa Brasileira De Pesquisa Agropecuaria Embrapa | Bacterial plaque evidencing composition based on natural colorants |
GB0303677D0 (en) * | 2003-02-18 | 2003-03-19 | Quest Int | Flavoured products |
US20040187888A1 (en) * | 2003-03-31 | 2004-09-30 | Lisa Vandyke | Dental hygiene maintenance kit for dental braces patients |
US8524198B2 (en) * | 2003-06-20 | 2013-09-03 | Donald W. Bailey | Xylitol dental maintenance system |
US9241885B2 (en) * | 2004-01-29 | 2016-01-26 | The Procter & Gamble Company | Oral care compositions comprising increased bioavailable levels of quaternary ammonium antimicrobials |
US20060280700A1 (en) * | 2005-06-08 | 2006-12-14 | Isler Stuart L | Oral hygiene system to fight the effects of aging on the mouth, gums, and teeth |
CN101370442A (zh) * | 2006-02-17 | 2009-02-18 | 宝洁公司 | 口腔护理方案及装置 |
-
2007
- 2007-04-05 JP JP2009504275A patent/JP2009533344A/ja active Pending
- 2007-04-05 RU RU2008138398/15A patent/RU2493816C2/ru not_active IP Right Cessation
- 2007-04-05 EP EP07754835A patent/EP2004134A2/en not_active Withdrawn
- 2007-04-05 BR BRPI0710643-2A patent/BRPI0710643A2/pt not_active Application Discontinuation
- 2007-04-05 MX MX2008012908A patent/MX2008012908A/es not_active Application Discontinuation
- 2007-04-05 US US11/732,927 patent/US20070237726A1/en not_active Abandoned
- 2007-04-05 WO PCT/US2007/008377 patent/WO2007117498A2/en active Application Filing
- 2007-04-05 AU AU2007235491A patent/AU2007235491A1/en not_active Abandoned
- 2007-04-05 CN CNA2007800103256A patent/CN101495085A/zh active Pending
- 2007-04-05 CA CA2648679A patent/CA2648679C/en not_active Expired - Fee Related
-
2008
- 2008-09-29 MY MYPI20083871A patent/MY157987A/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10175835A (ja) * | 1996-12-18 | 1998-06-30 | Atsushi Takatori | 歯垢染色歯磨剤 |
JP2004083443A (ja) * | 2002-08-23 | 2004-03-18 | Hideji Watanabe | マスティックを用いた歯周病予防・治療用組成物及び歯周病予防・治療方法 |
WO2005030141A2 (en) * | 2003-09-26 | 2005-04-07 | Morinda, Inc. | Morinda citrifolia-based oral care compositions and methods |
WO2006020875A2 (en) * | 2004-08-12 | 2006-02-23 | The Procter & Gamble Company | Oral compositions and systems |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009536663A (ja) * | 2006-05-09 | 2009-10-15 | コルゲート・パーモリブ・カンパニー | 口腔ケア措置 |
JP2017523218A (ja) * | 2014-08-15 | 2017-08-17 | ザ プロクター アンド ギャンブル カンパニー | 漸増式薬品を有する歯磨剤 |
JP2017523993A (ja) * | 2014-08-15 | 2017-08-24 | ザ プロクター アンド ギャンブル カンパニー | 強化された感覚的経験を有する口腔ケア組成物 |
JP2017524711A (ja) * | 2014-08-15 | 2017-08-31 | ザ プロクター アンド ギャンブル カンパニー | 口腔ケア組成物及びレジメン |
Also Published As
Publication number | Publication date |
---|---|
RU2008138398A (ru) | 2010-05-20 |
WO2007117498A3 (en) | 2009-03-12 |
MX2008012908A (es) | 2008-10-13 |
US20070237726A1 (en) | 2007-10-11 |
EP2004134A2 (en) | 2008-12-24 |
AU2007235491A1 (en) | 2007-10-18 |
WO2007117498A2 (en) | 2007-10-18 |
CA2648679A1 (en) | 2007-10-18 |
MY157987A (en) | 2016-08-30 |
CN101495085A (zh) | 2009-07-29 |
RU2493816C2 (ru) | 2013-09-27 |
BRPI0710643A2 (pt) | 2011-08-23 |
CA2648679C (en) | 2014-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2648679C (en) | Oral care regimens and kits | |
RU2719414C1 (ru) | Лечебные стоматологические пасты и связанные с ними способы и наборы | |
RU2431464C2 (ru) | Композиция средства для чистки зубов, не содержащая алкилсульфата и ортофосфата, содержащая источник фторида и абразив для зубов на основе диоксида кремния | |
Hegazy et al. | Antiplaque and remineralizing effects of Biorepair mouthwash: A comparative clinical trial | |
KR101308920B1 (ko) | 치아의 탈광화를 감소시키기 위한 조성물 및 방법 | |
Sensabaugh et al. | Stannous fluoride dentifrice with sodium hexametaphosphate: review of laboratory, clinical and practice-based data | |
CN106913470B (zh) | 洁齿剂组合物 | |
US9241889B2 (en) | Oral compositions comprising sodium dodecylbenzene sulfonate | |
JP5926238B2 (ja) | 新規組成物 | |
Ayad et al. | Comparative efficacy of a specially engineered sonic powered toothbrush with unique sensing and control technologies to two commercially available power toothbrushes on established plaque and gingivitis | |
JP2008504109A (ja) | 歯の咬合面における抗齲蝕効力を評価するための方法 | |
US20130022554A1 (en) | Oral care formulations | |
Clark | Remineralization effectiveness of MI Paste Plus-a clinical pilot study | |
Tiwari et al. | Remineralizing Potential of Low-fluoridated, Nonfluoridated and Herbal Nonfluoridated Dentifrices on Demineralized Surface of Primary Teeth: An In Vitro Study | |
Altınışık et al. | Evaluation of the activities of toothpastes with different contents in the prevention of enamel demineralization: An in vitro study | |
KR20220119700A (ko) | 치아 에나멜을 재광화하기 위한 조성물 | |
Barker et al. | Comparison of a Stabilized Stannous Fluoride/Sodium Hexametaphosphate Dentifrice and by Digital Plaque Imaging (DPIA) with White Light Illumination |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20110609 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110614 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20110914 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20110916 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20110922 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20110928 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20111214 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20120727 |